Resolution of amisulpride-associated amenorrhea by switching to aripiprazole

Bun Hee Lee, Yong Ku Kim

    Research output: Contribution to journalArticlepeer-review

    2 Citations (Scopus)


    Objective: To report a 4-case series in which amisulpride-induced symptomatic hyperprolactinemia was resolved by switching to aripiprazole. Case Reports: Four female patients developed symptomatic hyperprolactinemia such as amenorrhea and/or galactorrhea with elevated serum prolactin levels (113.7-230.0 ng/mL) after taking amisulpride (200-800 mg/day). To resolve the problem of symptomatic hyperprolactinemia, reducing the dosage of amisulpride was first tried, however this approach turned out to have no effect. Subsequently, all 4 patients were switched from amisulpride to aripiprazole (10-20 mg/day), upon which their regular menstrual cycles returned and galactorrhea improved, with the normalization of their serum prolactin levels (6.5-15.0 ng/mL) within 4 weeks after switching. Conclusion: Switching to aripiprazole, a partial dopamine agonist, is an effective strategy for the resolution of antipsychotic-induced hyperprolactinemia and associated adverse effects.

    Original languageEnglish
    Pages (from-to)102-106
    Number of pages5
    JournalPsychiatry Investigation
    Issue number1
    Publication statusPublished - 2006 Feb


    • Amenorrhea
    • Amisulpride
    • Aripiprazole
    • Galactorrhea
    • Prolactin

    ASJC Scopus subject areas

    • Psychiatry and Mental health
    • Biological Psychiatry


    Dive into the research topics of 'Resolution of amisulpride-associated amenorrhea by switching to aripiprazole'. Together they form a unique fingerprint.

    Cite this